BACKGROUND: Seven affected members are described from a kindred with autosomal dominant familial Alzheimer's disease associated with a novel mutation in the presenilin 1 (PS1) gene on chromosome 14 that results in a leucine to serine substitution at codon 250 (L250S). METHOD: Clinical information on the pedigree was collected directly from family members including affected members and their carers and also from hospital records. RESULTS: Detailed clinical information was available on five members. All had an early age at onset with a median age of 52 (95% confidence interval (95% CI) 49.4-54.9). Age at onset varied between 49 and 56 years, with duration of illness varying between six years and 15 years. Myoclonus, depression, and psychosis were features of this pedigree; seizures were not reported. CONCLUSIONS: PS1 L250S familial Alzheimer's disease is an early onset form of Alzheimer's disease with clinical features similar to other reported familial Alzheimer's disease pedigrees, except that seizures were absent.
BACKGROUND: Seven affected members are described from a kindred with autosomal dominant familial Alzheimer's disease associated with a novel mutation in the presenilin 1 (PS1) gene on chromosome 14 that results in a leucine to serine substitution at codon 250 (L250S). METHOD: Clinical information on the pedigree was collected directly from family members including affected members and their carers and also from hospital records. RESULTS: Detailed clinical information was available on five members. All had an early age at onset with a median age of 52 (95% confidence interval (95% CI) 49.4-54.9). Age at onset varied between 49 and 56 years, with duration of illness varying between six years and 15 years. Myoclonus, depression, and psychosis were features of this pedigree; seizures were not reported. CONCLUSIONS:PS1L250Sfamilial Alzheimer's disease is an early onset form of Alzheimer's disease with clinical features similar to other reported familial Alzheimer's disease pedigrees, except that seizures were absent.
Authors: M Haltia; M Viitanen; R Sulkava; V Ala-Hurula; M Poyhonen; L Goldfarb; P Brown; E Levy; H Houlden; R Crook Journal: Ann Neurol Date: 1994-09 Impact factor: 10.422
Authors: T H Lampe; T D Bird; D Nochlin; E Nemens; S C Risse; S M Sumi; R Koerker; B Leaird; M Wier; M A Raskind Journal: Ann Neurol Date: 1994-09 Impact factor: 10.422
Authors: A M Kennedy; S K Newman; R S Frackowiak; V J Cunningham; P Roques; J Stevens; D Neary; C J Bruton; E K Warrington; M N Rossor Journal: Brain Date: 1995-02 Impact factor: 13.501
Authors: M Mullan; H Houlden; M Windelspecht; L Fidani; C Lombardi; P Diaz; M Rossor; R Crook; J Hardy; K Duff Journal: Nat Genet Date: 1992-12 Impact factor: 38.330
Authors: G D Schellenberg; T D Bird; E M Wijsman; H T Orr; L Anderson; E Nemens; J A White; L Bonnycastle; J L Weber; M E Alonso Journal: Science Date: 1992-10-23 Impact factor: 47.728
Authors: R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop Journal: Nature Date: 1995-06-29 Impact factor: 49.962
Authors: D Campion; C Dumanchin; D Hannequin; B Dubois; S Belliard; M Puel; C Thomas-Anterion; A Michon; C Martin; F Charbonnier; G Raux; A Camuzat; C Penet; V Mesnage; M Martinez; F Clerget-Darpoux; A Brice; T Frebourg Journal: Am J Hum Genet Date: 1999-09 Impact factor: 11.025
Authors: Patricia A Wilkosz; Chowdari Kodavali; Elise A Weamer; Sachiko Miyahara; Oscar L Lopez; Vishwajit L Nimgaonkar; Steven T DeKosky; Robert A Sweet Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2007-12-05 Impact factor: 3.568